These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 26451771)
21. Novel Benzoxazin-3-one Derivatives: Design, Synthesis, Molecular Modeling, Anti-HIV-1 and Integrase Inhibitory Assay. Safakish M; Hajimahdi Z; Vahabpour R; Zabihollahi R; Zarghi A Med Chem; 2020; 16(7):938-946. PubMed ID: 31448713 [TBL] [Abstract][Full Text] [Related]
22. Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids. Nair V; Okello M Molecules; 2015 Jul; 20(7):12623-51. PubMed ID: 26184144 [TBL] [Abstract][Full Text] [Related]
23. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores. Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623 [TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors. Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 5-fluoroquinolone-3-carboxylic acids as potential HIV-1 integrase inhibitors. He QQ; Zhang X; Yang LM; Zheng YT; Chen F J Enzyme Inhib Med Chem; 2013 Aug; 28(4):671-6. PubMed ID: 22468749 [TBL] [Abstract][Full Text] [Related]
26. [Advances in the study of HIV-1 integrase inhibitors of alpha, gamma-diketo compounds]. Yu SH; Tan YM; Zhao GS Yao Xue Xue Bao; 2010 Feb; 45(2):215-23. PubMed ID: 21351431 [TBL] [Abstract][Full Text] [Related]
28. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors. Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621 [TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors. Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762 [TBL] [Abstract][Full Text] [Related]
30. Advances in the development of HIV integrase strand transfer inhibitors. Wang Y; Gu SX; He Q; Fan R Eur J Med Chem; 2021 Dec; 225():113787. PubMed ID: 34425310 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors. Li X; Vince R Bioorg Med Chem; 2006 Aug; 14(16):5742-55. PubMed ID: 16753300 [TBL] [Abstract][Full Text] [Related]
32. Conformationally restrained carbazolone-containing alpha,gamma-diketo acids as inhibitors of HIV integrase. Li X; Vince R Bioorg Med Chem; 2006 May; 14(9):2942-55. PubMed ID: 16386908 [TBL] [Abstract][Full Text] [Related]
33. Caffeoyl naphthalenesulfonamide derivatives as HIV integrase inhibitors. Xu YW; Zhao GS; Shin CG; Zang HC; Lee CK; Lee YS Bioorg Med Chem; 2003 Aug; 11(17):3589-93. PubMed ID: 12901903 [TBL] [Abstract][Full Text] [Related]
34. Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors. Pais GC; Zhang X; Marchand C; Neamati N; Cowansage K; Svarovskaia ES; Pathak VK; Tang Y; Nicklaus M; Pommier Y; Burke TR J Med Chem; 2002 Jul; 45(15):3184-94. PubMed ID: 12109903 [TBL] [Abstract][Full Text] [Related]
35. Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action. Di Santo R; Costi R; Roux A; Artico M; Lavecchia A; Marinelli L; Novellino E; Palmisano L; Andreotti M; Amici R; Galluzzo CM; Nencioni L; Palamara AT; Pommier Y; Marchand C J Med Chem; 2006 Mar; 49(6):1939-45. PubMed ID: 16539381 [TBL] [Abstract][Full Text] [Related]
36. Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: selection of the scaffold. Jones ED; Vandegraaff N; Le G; Choi N; Issa W; Macfarlane K; Thienthong N; Winfield LJ; Coates JA; Lu L; Li X; Feng X; Yu C; Rhodes DI; Deadman JJ Bioorg Med Chem Lett; 2010 Oct; 20(19):5913-7. PubMed ID: 20727748 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and molecular docking of calix[4]arene-based β-diketo derivatives as HIV-1 integrase inhibitors. Luo Z; Zhao Y; Ma C; Li Z; Xu X; Hu L; Huang N; He H Arch Pharm (Weinheim); 2015 Mar; 348(3):206-13. PubMed ID: 25682937 [TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens. Rashamuse TJ; Harrison AT; Mosebi S; van Vuuren S; Coyanis EM; Bode ML Bioorg Med Chem; 2020 Jan; 28(1):115210. PubMed ID: 31753802 [TBL] [Abstract][Full Text] [Related]
39. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase. Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and HIV-1 integrase inhibitory activities of caffeoylglucosides. Kim SN; Lee JY; Kim HJ; Shin CG; Park H; Lee YS Bioorg Med Chem Lett; 2000 Aug; 10(16):1879-82. PubMed ID: 10969990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]